1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Cancer of Colon in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drewinko, B; Yang, LY | 1 |
| Earhart, RH; Engstrom, PF; Hahn, RG; Moertel, C; Ramirez, G; Woodhouse, CL | 1 |
| Bedikian, AY; Bennetts, RW; Bodey, GP; Karlin, DA; Stewart, DJ; Stroehlein, JR | 1 |
| Baker, LH; Pazdur, R; Samson, MK | 1 |
4 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Cancer of Colon
| Article | Year |
|---|---|
The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.
Topics: Antineoplastic Agents; Cell Line; Colonic Neoplasms; DNA Repair; Humans; Kinetics; Nitrosourea Compounds; Rectal Neoplasms | 1983 |
Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Rectal Neoplasms; Time Factors | 1984 |
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Rectal Neoplasms | 1983 |
PCNU: phase II evaluation in advanced colorectal carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Humans; Middle Aged; Nitrosourea Compounds; Rectal Neoplasms | 1988 |